Pilot study identifies specific H. pylori strain as chief risk factor for stomach cancer
Researchers at Fred Hutchinson Cancer Research Center have found a specific strain of Helicobacter pylori…
Browsing: GI Cancers
Half of over-60s ignore lifesaving bowel cancer screening
Half (51%) of people invited to bowel screening for the first time in 2015 didn’t…
Genetic ‘forecasting’ could predict bowel cancer’s response to treatment
Blood tests could predict how long it takes until bowel cancer returns based on the…
Anti-inflammatory use during surgery could improve cancer outcomes
The world’s first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in…
Treatment for severe heartburn prevents cancer
Medical or surgical treatment of severe heartburn prevents cancer of the oesophagus, a study from…
Simple test could identify bladder cancer patients who won’t respond to immunotherapy
Patients who are unlikely to benefit from a commonly used immunotherapy for bladder cancer could…
Doxorubicin disrupts the immune system to cause heart toxicity
Doxorubicin is a chemotherapy drug widely used in ovarian, bladder, lung, thyroid and stomach cancers,…
Rewriting our understanding of gastric tumours
The immune system can be an important ally in the fight against cancer. A study…
Cancer costs Australian health services over $6 billion a year: new research
New research by Cancer Council NSW has revealed the cost of cancer to Australia’s health…
Association of complementary medicine, cancer treatment, survival
The use of complementary medicine by patients with four common cancers (breast, prostate, lung or…